Canine Visceral Leishmaniasis in Colombia Resistant to the Treatment of Choice (Meglumine Antimoniate Plus Allopurinol)

5Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

This paper describes a case of canine visceral Leishmaniasis resistant to Meglumine Antimoniate plus allopurinol treatment in a canine patient from Colombia. A one-year-old castrated dog of the schnauzer breed was referred for veterinary consultation for showing a 2-month history of dermatological lesions on the back of the body and tail. Clinical examination revealed circular and ulcerative alopecic lesions delimited by a high relief border. Based on the clinical examination and laboratory analysis, canine leishmaniasis by Leishmania infantum was established as a diagnosis. The patient was treated with Glucantime® (50mg/kg subcutaneously twice daily for 4 weeks) plus Allopurinol® (10mg/kg twice a day orally for 10 months). Eight weeks after began treatment lesions had disappeared. However, two months later there was a clinical relapse. To our knowledge, it is the first report of resistance of canine Leishmaniasis to Glucantime® plus allopurinol in Colombia.

Cite

CITATION STYLE

APA

Pinilla, J. C., Gutierrez, A., & Florez, A. A. (2022). Canine Visceral Leishmaniasis in Colombia Resistant to the Treatment of Choice (Meglumine Antimoniate Plus Allopurinol). International Journal of Veterinary Science, 11(1), 117–120. https://doi.org/10.47278/journal.ijvs/2021.103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free